CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Canada
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Ottawa
- Age
- 18 years and over
- People
- 201 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00 - Phase 2Taking peopleA Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Calgary, Toronto
- Age
- 18 years and over
- People
- 36 worldwide
- Run by
- Takeda
See details and how to joinNCT06798012 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Calgary, Edmonton, Vancouver
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - Phase 3Enrolling by invitationLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Gatineau, Québec
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - Phase 3Taking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- London, Montreal, Québec, Toronto
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - Phase 1Taking peopleStudy of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Where
- Montreal, Ottawa
- Age
- 18 years to 75 years
- People
- 57 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07304154